Neurological manifestations in m.3243A>G-related disease triggered by metformin

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition

Pouya Saeedi, Inga Petersohn, Belma Malanda et al. · Diabetes Research and Clinical Practice · 2019 · 10.5K citations

Medicine, Chronic Disease Prevention, Endocrinology +14

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

Anila K. Madiraju, Derek M. Erion, Yasmeen Rahimi et al. · Nature · 2014 · 1.3K citations

Life Sciences, Biochemistry, Endocrinology +12

Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNA(Leu(UUR)) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Michael P. King, Yasutoshi Koga, Mercy M. Davidson et al. · Molecular and Cellular Biology · 1992 · 350 citations

Life Sciences, Genetics, Molecular Biology +17

Maternally Inherited Diabetes and Deafness: A Multicenter Study

P.-J. Guillausseau, Pascale Massin, Danièle Dubois‐Laforgue et al. · Annals of Internal Medicine · 2001 · 310 citations

Life Sciences, Genetics, Internal Medicine +15

Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats

Qingmiao Shao, Lei Meng, Sharen Lee et al. · Cardiovascular Diabetology · 2019 · 295 citations · Full text

Medicine, Cardiology, Pharmacology +17